ANAB - CIK 0001370053
ANAPTYSBIO, INC (ANAB) reported revenue of $234.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $234.60M | +157.0% |
| FY 2024 | $91.28M | +432.0% |
| FY 2023 | $17.16M | +66.8% |
| FY 2022 | $10.29M | -83.7% |
| FY 2021 | $63.17M | -15.8% |
| FY 2020 | $75.00M | +837.5% |
| FY 2019 | $8.00M | +60.0% |
| FY 2018 | $5.00M | -50.0% |
| FY 2017 |
ANAPTYSBIO, INC (ANAB) reported revenue of $234.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2015 and fiscal 2025, ANAPTYSBIO, INC's revenue grew from $17.57M to $234.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.00M |
| -40.1% |
| FY 2016 | $16.68M | -5.0% |
| FY 2015 | $17.57M | - |